338 related articles for article (PubMed ID: 18018780)
1. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
[TBL] [Abstract][Full Text] [Related]
2. [Administration of exogenous surfactant in premature very low birth weight infants with RDS].
Iarŭkova N; Vakrilova L; Slŭncheva B; Dancheva S; Popivanova A; Emilova Z; Dimitrov A; Chernev T; Nikolov A
Akush Ginekol (Sofiia); 1999; 38(1):23-6. PubMed ID: 11965714
[TBL] [Abstract][Full Text] [Related]
3. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
4. [Problems and outcome in extremely low birth weight newborns, depending on the mode of delivery].
Vakrilova L; Emilova Z; Slŭncheva B; Dimitrov A; Nikolov A; Iarŭkova N
Akush Ginekol (Sofiia); 2002; 41(2):24-7. PubMed ID: 12066546
[TBL] [Abstract][Full Text] [Related]
5. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.
Ramanathan R; Siassi B; deLemos RA
J Perinatol; 1995; 15(3):178-82; quiz 183-4. PubMed ID: 7666264
[TBL] [Abstract][Full Text] [Related]
6. [Use and efficacy of treatment with porcine surfactant in newborns with birth weight < or = 1000 g: experience in 3 years].
Brusamento S; Buffo M; Carnielli VP
Pediatr Med Chir; 1999; 21(6):261-5. PubMed ID: 11293146
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
[TBL] [Abstract][Full Text] [Related]
8. The effects of intrauterine cocaine exposure on the respiratory status of the very low birth weight infant.
Hand IL; Noble L; McVeigh TJ; Kim M; Yoon JJ
J Perinatol; 2001 Sep; 21(6):372-5. PubMed ID: 11593371
[TBL] [Abstract][Full Text] [Related]
9. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
10. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
[TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome.
Srisuparp P; Heitschmidt M; Schreiber MD
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S469-78. PubMed ID: 12403222
[TBL] [Abstract][Full Text] [Related]
12. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
Geary C; Caskey M; Fonseca R; Malloy M
Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
[TBL] [Abstract][Full Text] [Related]
13. Antenatal corticosteroid therapy in premature infants.
Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
Modanlou HD; Beharry K; Padilla G; Iriye B
J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
[TBL] [Abstract][Full Text] [Related]
15. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum cortisol levels in a relatively large and mature group of ventilated and nonventilated preterm infants with respiratory distress syndrome.
Gunes T; Koklu E; Ozturk MA; Koklu S; Cetin N
Am J Perinatol; 2006 Aug; 23(6):335-9. PubMed ID: 16841278
[TBL] [Abstract][Full Text] [Related]
17. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao.
Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD
West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907
[TBL] [Abstract][Full Text] [Related]
18. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
[TBL] [Abstract][Full Text] [Related]
19. Drug utilisation in very preterm infants: any changes during the past decade?
Lindner U; Hilgendorff A; Frey G; Gortner L
Klin Padiatr; 2008; 220(4):238-42. PubMed ID: 18401813
[TBL] [Abstract][Full Text] [Related]
20. A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (SNIPPV) as a primary mode of ventilation in infants > or = 28 weeks with respiratory distress syndrome (RDS).
Santin R; Brodsky N; Bhandari V
J Perinatol; 2004 Aug; 24(8):487-93. PubMed ID: 15141265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
